The Value of miR-296 and miR-517c in Evaluating the Prognosis of Patients with Glioma after Radiotherapy and Chemotherapy

Table 4

Comparison of serum miR-296 and miR-517c levels before chemotherapy between the effective group and the ineffective group ( ± S).

Groups	n	Serum miR-296	Serum miR-517c
Effective group	366	4.62 ± 0.53	4.44 ± 2.15
Ineffective group	366	2.94 ± 1.88	2.66 ± 1.39
t		16.455	13.301
		<0.001	<0.001